EWTX FY 2022 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

EWTXEdgewise Therapeutics, Inc.

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$72M

Net Income

-$68M

EPS (Diluted)

$-1.26

Cash Flow

Operating Cash Flow

-$53M

Free Cash Flow

-$58M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$367M

Total Liabilities

$20M

Stockholders' Equity

$347M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$72M	-$43M	-65.8%
Net Income	-$68M	-$43M	-58.0%